Maraviroc is an antiretroviral medication used in the treatment of HIV-1 infection, primarily acting as a CCR5 receptor antagonist to prevent viral entry into host cells. Unlike other classes of HIV drugs, Maraviroc targets the host cell rather than the virus itself, offering a unique mechanism of action. Maintaining the pharmaceutical purity of Maraviroc is essential to ensure its safety, efficacy, and compliance with regulatory standards. Impurity profiling is crucial for detecting and controlling unwanted by-products that may arise during synthesis, formulation, or storage. Here are some of its known impurities listed below.
Showing 1 - 1 of 1 products
Catalogue No : MARA-OCL-001
CAS No : 376348-65-1
In Stock
Synonyms
4,4-Difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl-d6)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]cyclohexane carbox...More Detail
4,4-Difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl-d6)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]cyclohexane carbox...More Detail